Overview:
The global age-related macular degeneration (AMD) market is all set to expand, as per MRFR study of the same market, with a 7.80% CAGR during the forecast period (2018-2023). In the process, it would garner a valuation of USD 11,186.8 Million by the end of 2023. Age-related macular degeneration is a disease that lessens the sharp focus of eyesight that is required mostly for reading, sewing, and other such activities. The sight at the center becomes blurry and creates discomfort for the patient by creating some blank spots there. The disease mostly appears in aged people.
Among the drivers of the age-related macular degeneration market, patent expiry of a significant number of drugs has created an opportunity for a lot of new entrants to engage in the vacant space. This would also encourage a reduction in price and hence, increasing the number of takers. However, the age-related macular degeneration market can face some daunting task to overcome hindrances posed by insurance claims.
Market Segmentation
The Market Research Future report offers a complete segmental analysis of the age-related macular degeneration market based on end user, route of administration, treatment, age group, stages, and type.
By type, the age-related macular degeneration market is segmented into dry age-related macular degeneration (dry AMD) and wet age-related macular degeneration (wet AMD). Of these, the wet age-related macular degeneration (wet AMD) segment will lead the market during the forecast period.
By stages, the age-related macular degeneration market is segmented into late-stage age-related macular degeneration, early-stage age-related macular degeneration, and intermediate-stage age-related macular degeneration. Of these, the intermediate-stage age-related macular degeneration segment will dominate the market during the forecast period.
By age group, the age-related macular degeneration market is segmented into 40 years, above 60 years, and above 75 years. Of these, the above 75 years segment will have the maximum share in the market during the forecast period.
By treatment, the age-related macular degeneration market is segmented into diagnosis and treatment. Of these, the treatment segment will dominate the market during the forecast period.
By route of administration, the age-related macular degeneration market is segmented into the intravenous route of administration and intravitreal route of administration. Of these, the intravitreal route of administration will have the largest share in the market during the forecast period.
By end user, the age-related macular degeneration market is segmented into academic research institutes, diagnostic centers, and hospitals & clinics. Among these, hospitals and clinics will lead the market during the forecast period.
Market Regional Analysis:
The age related macular degeneration market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas is projected to hold a dominant share of the global market through the forecast period. The rising burden of the disease in the region is expected to drive the proliferation of the regional market. According to the Centers for Disease Control and Prevention (CDC), 1.8 million people were suffering from the disease in 2015 in the U.S.
Europe is an important growth pocket placed at the second position in the marketplace. It is predicted to benefit from rising geriatric population and increasing healthcare expenditure. Meanwhile, Asia Pacific is likely to emerge as the fastest growing regional market for AMD over the assessment period. The factors that are responsible for favoring the expansion of the age-related macular degeneration market in the region are rising healthcare expenditure, increasing prevalence of eye-disorders, growing geriatric population, etc.
Competitive Landscape:
MRFR in their report on the age-related macular degeneration market included Regeneron Pharmaceutical Inc., F. Hoffmann-La Roche AG, Santen Pharmaceuticals, Novartis AG, Bayer AG, and others as possible market influencers.
In January 2019, researchers from the University of Liverpool discovered new genes that can be linked with age-related macular degeneration. This could lead to proper treatment for the disease as the root cause for the disease is still unclear.
Key Players
Notable players profiled in the age-related macular degeneration market report include Bausch & Lomb Incorporate, ALLERGAN, Santen Pharmaceuticals Co., Alimera Sciences Inc., Regeneron Pharmaceutical Inc., Rxi Pharmaceuticals, Inc., Bayer AG, GlaxoSmithKline PLC, Ophthotech Corporation, Acucela Inc., F. Hoffmann-La Roche AG, and Novartis AG, Pfizer Inc.
Industry News
October 2019: Brolucizumab injection for wet-AMD (age-related macular degeneration) has received US FDA approval.
1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition 26
3.2 Scope of the Study 26
3.3 Assumptions & Limitations 26
3.3.1 Assumptions 26
3.3.2 Limitations 26
3.4 Market Structure 27
4 Research Methodology
4.1 Research Process 29
4.2 Primary Research 30
4.3 Secondary Research 31
4.4 Market Size Estimation 31
4.5 Forecast Model 32
5 Market Dynamics
5.1 Introduction 34
5.2 Drivers 35
5.2.1 Growing Geriatric Population and Increasing Prevalence of Age–Related Macular Degeneration 35
5.2.2 Several Branded Drugs Going Off Patent 35
5.3 Restraints 36
5.3.1 High Cost Associated With AMD 36
5.3.2 Stringent FDA Regulations 36
5.4 Opportunities 36
5.4.1 Strong pipeline 36
5.5 Pipeline Analysis 37
5.5.1 Brolucizumab 6 mg 37
5.5.2 NCT01691261 37
5.5.3 NCT03102138 38
5.5.4 Lampalizumab 38
5.5.5 RG7716 38
5.5.6 Emixustat 38
5.5.7 Zimura Dry AMD 39
5.5.8 Zimura Wet AMD 39
5.5.9 GSK933776 39
5.5.10 RXI–109 39
5.5.11 Abicipar Pegol 40
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half- Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
